Xeris Biopharma Holdings Inc
XERS
Market Cap$329.13M
Close$
$2.89
28.5% upside
Current Fair Value
28.5% upsideUndervalued by 28.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $329.13 Million |
|---|---|
| Enterprise Value | $510.47 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.46 |
| Beta | 1.84 |
| Outstanding Shares | 148,255,663 |
| Avg 30 Day Volume | 1,423,203 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.11 |
|---|---|
| PEG | -40.09 |
| Price to Sales | 2.25 |
| Price to Book Ratio | -2.25 |
| Enterprise Value to Revenue | 2.98 |
| Enterprise Value to EBIT | -11.35 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.53 |
| Debt to Equity | -29.28 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Xeris Pharmaceuticals Inc
CEO: paul Edick